Trial of JMKX003142 in Participants With Rapidly Progressive Autosomal Dominant Polycystic Kidney Disease (ADPKD)

NCT06800651 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

135

Enrollment

INDUSTRY

Sponsor class

Conditions

ADPKD (Autosomal Dominant Polycystic Kidney Disease)

Interventions

DRUG: JMKX003142 will be administered orally
DRUG: Plcacebo

Sponsor

Jemincare